The ARITMO project, aimed to analyse the cardiac safety profile of antipsychotics, anti-infectives and H1-anti-histamines, was approved for funding by the European Commission within the 7th Framework Program in 2009. The project is coordinated by Professor M. Sturkenboom, from the Erasmus Medical Centre (Rotterdam). The University of Bologna is one of the ARITMO partners. F. De Ponti is the local coordinator at UNIBO and member of the steering committee. The objectives of the project (2010-2012) are: • To assess the reporting rate and relative risk of QTc prolongation, TdP, ventricular fibrillation and sudden death from regional and international pharmacovigilance databases. • To assess the rate and relative risk of symptomatic QTc prolongation, TdP, ventricular fibrillation and sudden death during use of study drugs.
ARITMO / Sturkenboom M.; De Ponti F.; Garbe E.; Behr E.; Molokhia M.. - (2009).
ARITMO
DE PONTI, FABRIZIO;
2009
Abstract
The ARITMO project, aimed to analyse the cardiac safety profile of antipsychotics, anti-infectives and H1-anti-histamines, was approved for funding by the European Commission within the 7th Framework Program in 2009. The project is coordinated by Professor M. Sturkenboom, from the Erasmus Medical Centre (Rotterdam). The University of Bologna is one of the ARITMO partners. F. De Ponti is the local coordinator at UNIBO and member of the steering committee. The objectives of the project (2010-2012) are: • To assess the reporting rate and relative risk of QTc prolongation, TdP, ventricular fibrillation and sudden death from regional and international pharmacovigilance databases. • To assess the rate and relative risk of symptomatic QTc prolongation, TdP, ventricular fibrillation and sudden death during use of study drugs.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
